Saturn V Capital Management LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $249 Billion distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Crinetics Pharmaceuticals, Inc. with a value of $30.9B, Argenx Se with a value of $25.8B, Cytokinetics Inc with a value of $18.5B, Kal Vista Pharmaceuticals, Inc. with a value of $17.1B, and Merus N.V. with a value of $17B.

Examining the 13F form we can see an decrease of $11.8B in the current position value, from $261B to 249B.

Saturn V Capital Management LLC is based out at Austin, TX

Below you can find more details about Saturn V Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $249 Billion
Healthcare: $211 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 21
  • Current Value $249 Billion
  • Prior Value $261 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 5 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.